News-Yaohai Biopharmaceutical Co., Ltd.

News

Methods to Improve the Yield of pDNA

Sep 11, 2024

The production of plasmid DNA (pDNA) relies on genetic recombination, which involves connecting the target gene and other elements to form a covalently closed circular structure. High cell-density fermentation of Escherichia coli and purification are...

Congratulations to Yaohai’s CDMO Client
Aug 15, 2024
Good news! Northland Biotech's Naked Plasmid NL003 BLA was accepted by NMPA On July 16 2024, the valued client of Yaohai Bio-Pharma, Beijing Northland Biotechnology Co., Ltd. (Northland), announced that its independently developed Category 1 new th...
Read More
Yaohai Bio-Pharma Passed EU QP Audit and Attains ISO Triple Certification
May 08, 2024
Good news! Yaohai Bio-Pharma has recently passed the on-site audit by the European Union Qualified Person (QP) for the GMP quality system and production site. Additionally, it has cleared the initial certification audits for ISO9001 Quality Managemen...
Read More
WORLD VACCINE CONGRESS Washington
Apr 08, 2024
The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meetings of their kind across the globe. Following a record attendance in 2023 of 3000+ attendees,...
Read More